Clinical Trial Update: N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating N-methylglycine (sarcosine) for obsessive-compulsive disorder has completed; no efficacy results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Sarcosine (sarcosine)

Snippet

Sponsor: China Medical University Hospital | Conditions: Obsessive Compulsive Disorder | Phase 2 | Status: COMPLETED